In addition, splice redirection of Bcl-x pre-mRNA induced by 2'-MOE modified Bcl-xSSOs in glioma cells and melanoma xenograft models showed pro-apoptotic effect and reduced tumour load respectively [142, 143]. The gene discussed is BCL2L1; the disease is central nervous system cancer.